India has placed urgent orders for at least 11.45 crore tablets of hydroxychloroquine (HCQ). This drug is being directly procured by HLL Lifecare, on behalf of the Union health ministry. ......
The government has distributed more than 3.04 crore N95 masks and over 1.28 crore personal protection equipment (PPE) kits among the states, Union territories and central institutions for free......
The authors of a controversial study published in The Lancet journal linking the use of malaria drug hydroxychloroquine with increased death risk in COVID-19 patients, have retracted their research......
The once touted 'wonder drug' has been battling global controversies around its safety and efficacy as a prophylactic against COVID-19.However, India has stood by studies conducted by the ICMR and......
Terming World Health Organisation's decision to resume testing of hydroxychloroquine as a potential treatment for COVID-19 in its global clinical trial "a step in the right direction", experts said......
Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its......
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation. Even as the......
A leading exporter said, there is enough stock of paracetamol in the country. At present, the US, which has become the epicentre of the COVID-19 outbreak, needs paracetamol. He further said India......
This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus. Even as the US government......
India lost its competitive advantage as China gave fiscal benefits to its local manufacturers. Besides, recent policy flip-flops have, however, dented India’s image as the ‘pharmacy of......